A Randomized Study to Evaluate the Efficacy and Safety of Adding Topical Therapy to Etanercept in Subjects With Moderate to Severe Plaque Psoriasis.
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Clobetasol (Primary) ; Etanercept
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Amgen
- 05 Mar 2013 Primary endpoint 'Psoriasis-Area-and-Severity-Index-score-75%-response-criteria' has been met.
- 05 Mar 2013 Results presented at the 71st Annual Meeting of the American Academy of Dermatology.
- 17 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History